Isabel Rodríguez-Barraquer joins Chan Zuckerberg Biohub Investigators
The Eppicenter is delighted to announce our faculty member is included among the 2021 cohort of CZ Biohub Investigators.
The Chan Zuckerberg Biohub Investigator Program, open to faculty from Stanford, UCSF, and UC Berkeley, funds innovative, visionary research with the goal of building engaged, collaborative scientific communities to help solve critical challenges in biomedicine. Successful applicants receive $1 million in discretionary funds over a nonrenewable 5-year term ($200,000 per year). This year, 86 awardees were chosen from nearly 700 applicants, representing a diverse range of disciplines, including basic biological sciences, clinical biomedical sciences, physics, chemistry, engineering, computer and data sciences, statistics, and public health.
Dr Rodríguez-Barraquer, MD, PhD, is Co-Director of the EPPIcenter. She is an Assistant Professor in the Division of HIV, ID and Global Medicine, interested in applying novel epidemiological and statistical methods to understand the dynamics of infectious diseases. Much of her experience relates to vector-borne diseases such as dengue, malaria, and Zika, with more recent work in sero-epidemiological modeling for COVID-19 control.
Isabel completed her medical training at Pontificia Universidad Javeriana in Colombia, followed by a PhD in epidemiology and an MHS in Biostatistics at the Johns Hopkins Bloomberg School of Public Health in 2012. She has been based at UCSF since 2017.
Read more about the award, and find the full roster at the CZ Biohub announcement->>